FDA Approves First Generic Tulathromycin for Cattle & Swine
USAgNet - 02/22/2021
The FDA has approved the first two generic tulathromycin injectable products for the treatment and control of certain diseases in both cattle and swine.
Both generic products, Macrosyn and Increxxa, are approved for indications such as the treatment of bovine respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis in beef and non-lactating dairy cattle, suckling calves, dairy calves and veal calves.
It also helps control of respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis.
- Drought Spreads in Key U.S. Crop States
- China Flags New Rules for Commodity Price Indexes
- India to Boost Ethanol Production as Fuel Rise
- NPPC Urges Congress to Address Port Bottlenecks
- Tractor Supply Co. Breaks Ground on Ohio Distribution Center
- NASS Reschedules Reports Due to New Juneteenth Holiday
- U.S. Drought Monitor: Relief From Dry Conditions Is Hit or Miss